Search

Endocannabinoids in Liver Disease and Hepatic Encephalopathy

Journal: Current Pharmaceutical Design
Volume: 14 Issue: 2 Year: 2008 Page: 2362-2369
Author(s): Iddo Magen, Yosefa Avraham, Elliot Berry, Raphael Mechoulam

Hepatic Effects of Duloxetine-II: Spontaneous Reports and Epidemiology of Hepatic Events

Journal: Current Drug Safety
Volume: 3 Issue: 2 Year: 2008 Page: 143-153
Author(s): Joachim Wernicke, Nayan Acharya, Indiana Strombom, James L. Gahimer, Deborah N. DSouza, Natalie DiPietro, Jack P. Uetrecht

Potential Role of ADAMTS13 in the Progression of Alcoholic Hepatitis

Journal: Current Drug Abuse Reviews
Volume: 1 Issue: 2 Year: 2008 Page: 188-196
Author(s): Masahito Uemura, Yoshihiro Fujimura, Tomomi Matsuyama, Masanori Matsumoto, Masatoshi Ishikawa, Hiromichi Ishizashi, Seiji Kato, Tatsuhiro Tsujimoto, Masao Fujimoto, Hitoshi Yoshiji, Chie Morioka, Hiroshi Fukui

Hepatitis C Treatment in Patients with Drug Addiction: Clinical Management of Interferon-Alpha-Associated Psychiatric Side Effects

Journal: Current Drug Abuse Reviews
Volume: 1 Issue: 2 Year: 2008 Page: 177-187
Author(s): Martin Schaefer, Stefan Mauss

Cyclosporin and Organ Specific Toxicity: Clinical Aspects, Pharmacogenetics and Perspectives

Journal: Current Clinical Pharmacology
Volume: 3 Issue: 3 Year: 2008 Page: 166-173
Author(s): Alberto Magnasco, Andrea Rossi, Paolo Catarsi, Rosanna Gusmano, Fabrizio Ginevri, Francesco Perfumo, Gian Marco Ghiggeri

Enzyme Inhibition and Induction in Liver Disease

Journal: Current Clinical Pharmacology
Volume: 3 Issue: 1 Year: 2008 Page: 56-69
Author(s): Pietro Palatini, Sara De Martin, Paola Pegoraro, Rocco Orlando

Journal: Current Clinical Pharmacology
Volume: 3 Issue: 3 Year: 2008 Page: 156-165
Author(s): Robert Lo, Andrew Austin, Jan Freeman

Genomics Can Advance The Potential For Probiotic Cultures To Improve Liver And Overall Health

Journal: Current Pharmaceutical Design
Volume: 14 Issue: 1 Year: 2008 Page: 1376-1381
Author(s): Daniel J. OSullivan

Editorial [Hot topic: Endocannabinoid Signaling and Neuroinflammatory Diseases (Executive Editor: Mauro Maccarrone)]

Journal: Current Pharmaceutical Design
Volume: 14 Issue: 2 Year: 2008 Page: 2252-2253
Author(s): Mauro Maccarrone

PET Imaging of the Peripheral Benzodiazepine Receptor: Monitoring Disease Progression and Therapy Response in Neurodegenerative Disorders

Journal: Current Pharmaceutical Design
Volume: 14 Issue: 3 Year: 2008 Page: 3297-3315
Author(s): Janine Doorduin, Erik F.J. de Vries, Rudi A. Dierckx, Hans C. Klein